Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0048
-0.0007 (-12.73%)
At close: Sep 15, 2026
Petros Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.2 | 1.91 | -14.32 | -8.16 | -20.04 | -8.99 |
Depreciation & Amortization | - | - | - | 3.42 | 5.72 | 6.88 |
Other Amortization | - | - | - | - | - | 0.01 |
Loss (Gain) From Sale of Assets | - | -6.97 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 7.46 | - |
Stock-Based Compensation | 0.39 | 0.3 | 0.47 | 0.42 | 1.2 | 1.31 |
Provision & Write-off of Bad Debts | - | - | - | 0.03 | -0.17 | 0.15 |
Other Operating Activities | -0 | 0.68 | 10.06 | -3.95 | -3.87 | -9.46 |
Change in Accounts Receivable | - | - | - | -0.14 | 0.52 | 2.55 |
Change in Inventory | - | - | - | -0.91 | -0.84 | 0.41 |
Change in Accounts Payable | -0.87 | -0.68 | 0.35 | -0.09 | -2.75 | -1.05 |
Change in Unearned Revenue | - | - | - | -0.16 | 0.21 | - |
Change in Other Net Operating Assets | -0.03 | 0.02 | -0.62 | 1.94 | -0.23 | -3.67 |
Operating Cash Flow | -3.72 | -6.73 | -2.6 | -7.63 | -12.8 | -11.86 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Investing Activities | - | - | -0.02 | - | - | - |
Investing Cash Flow | - | - | -0.02 | - | - | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | -1.46 | -1.62 | -7.19 |
Net Debt Issued (Repaid) | - | - | - | -1.46 | -1.62 | -7.19 |
Issuance of Common Stock | - | 8.5 | - | 15 | - | 25.76 |
Other Financing Activities | - | - | -0.77 | - | - | - |
Financing Cash Flow | -0.12 | 8.16 | -7 | 11.54 | -1.62 | 18.57 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -3.83 | 1.43 | -9.63 | 3.91 | -14.42 | 6.71 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.72 | -6.73 | -2.6 | -7.63 | -12.8 | -11.86 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | -130.99% | -213.57% | -151.86% |
Free Cash Flow Per Share | -0.08 | -0.24 | -8.11 | -87.62 | -154.54 | -272.32 |
Levered Free Cash Flow | -1.82 | -12.78 | 7.59 | -1.39 | -26.93 | -5 |
Unlevered Free Cash Flow | -1.82 | -12.78 | 7.59 | -1.05 | -26.56 | -4.78 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | 0.54 | 0.6 | 0.42 |
Change in Working Capital | -0.9 | -0.66 | -0.27 | 0.62 | -3.09 | -1.76 |